• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-苄基-1-(2,4,6-三甲基金刚烷)-哌啶的合成、分子对接和计算机 ADMET 研究:SARS-CoV2 的潜在抑制剂。

Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2.

机构信息

Department of Chemistry and Research Centre, Pope's College (Autonomous), Sawyerpuram-628251, Affiliated to Manonmaniam Sundaranar University, Tirunelveli 627012, Tamil Nadu, India.

Department of Chemistry, Texas A&M University, College Station, TX 77842, USA.

出版信息

Bioorg Chem. 2021 Jul;112:104967. doi: 10.1016/j.bioorg.2021.104967. Epub 2021 May 5.

DOI:10.1016/j.bioorg.2021.104967
PMID:33975232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8096530/
Abstract

Nowadays, over 200 countries face a wellbeing emergency because of epidemiological disease COVID-19 caused by the SARS-CoV-2 virus. It will cause a very high effect on the world's economy and the worldwide health sector. The present work is an investigation of the newly synthesized 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine (M1BZP) molecule's inhibitory potential against important protein targets of SARS-CoV-2 using computational approaches. M1BZP crystallizes in monoclinic type with P1211 space group. For the title compound M1BZP, spectroscopic characterization like H NMR, C NMR, FTIR, were carried out. The geometry of the compound had been optimized by the DFT method and its results were compared with the X-ray diffraction data. The calculated energies for the Highest Occupied Molecular Orbital (HOMO) and the Lowest Unoccupied Molecular Orbital (LUMO) showed the stability and reactivity of the title compound. Intermolecular interactions in the crystal network were determined using Hirshfeld surface analyses. The molecular electrostatic potential (MEP) picture was drawn using the same level of theory to visualize the chemical reactivity and charge distribution on the molecule. Molecular docking study performed for the synthesized compound revealed an efficient interaction with the COVID-19 protease and resulted in good activities. We hope the present study would help workers in the field to develop potential vaccines and therapeutics against the novel coronavirus. Virtual ADME studies were carried out as well and a relationship between biological, electronic, and physicochemical qualifications of the target compound was determined. Toxicity prediction by computational technique for the title compound was also carried out.

摘要

如今,由于 SARS-CoV-2 病毒引起的流行病 COVID-19,超过 200 个国家面临着健康危机。这将对世界经济和全球卫生部门造成非常高的影响。本工作是通过计算方法研究新合成的 4-苄基-1-(2,4,6-三甲基苄基)-哌啶(M1BZP)分子对 SARS-CoV-2 重要蛋白靶标的抑制潜力。M1BZP 以单斜晶型结晶,空间群为 P1211。对标题化合物 M1BZP 进行了光谱特征分析,如 1 H NMR、13 C NMR、FTIR。采用密度泛函理论(DFT)方法优化了化合物的几何形状,并将其结果与 X 射线衍射数据进行了比较。计算出的最高占据分子轨道(HOMO)和最低未占据分子轨道(LUMO)的能量表明了标题化合物的稳定性和反应性。利用 Hirshfeld 表面分析确定了晶体网络中的分子间相互作用。使用相同的理论绘制了分子静电势(MEP)图,以可视化分子上的化学反应性和电荷分布。对合成化合物进行的分子对接研究表明,它与 COVID-19 蛋白酶具有有效的相互作用,并且具有良好的活性。我们希望本研究能帮助该领域的工作者开发针对新型冠状病毒的潜在疫苗和疗法。还进行了虚拟 ADME 研究,并确定了目标化合物的生物、电子和物理化学性质之间的关系。还通过计算技术对标题化合物进行了毒性预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/4a23809082a7/gr14_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/3bd845f561c1/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/411e1171592c/gr18_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/3666e3bfc87c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/9cf557afe23f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/97cf9f5e6f15/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/b5698ec4ce3e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/848e543571e8/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/1d00c4c3732b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/d8d659fd6c06/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/5095ffb6cf1b/gr8a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/2bc9ee8cadf1/gr8b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/9df854a2219f/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/bdd35cd11385/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/707ddcd97c53/gr11_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/d68d29886845/gr12_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/bfb390338030/gr13_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/4a23809082a7/gr14_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/3bd845f561c1/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/411e1171592c/gr18_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/3666e3bfc87c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/9cf557afe23f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/97cf9f5e6f15/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/b5698ec4ce3e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/848e543571e8/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/1d00c4c3732b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/d8d659fd6c06/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/5095ffb6cf1b/gr8a_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/2bc9ee8cadf1/gr8b_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/9df854a2219f/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/bdd35cd11385/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/707ddcd97c53/gr11_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/d68d29886845/gr12_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/bfb390338030/gr13_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c6/8096530/4a23809082a7/gr14_lrg.jpg

相似文献

1
Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2.4-苄基-1-(2,4,6-三甲基金刚烷)-哌啶的合成、分子对接和计算机 ADMET 研究:SARS-CoV2 的潜在抑制剂。
Bioorg Chem. 2021 Jul;112:104967. doi: 10.1016/j.bioorg.2021.104967. Epub 2021 May 5.
2
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.揭示瑞德西韦和核苷酸类似物对 SARS-CoV-2 的 RNA 依赖性 RNA 聚合酶(RdRp)的抑制机制:分子动力学模拟研究。
J Phys Chem B. 2020 Nov 25;124(47):10641-10652. doi: 10.1021/acs.jpcb.0c06747. Epub 2020 Nov 15.
3
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.比较瑞德西韦及其代谢物与 SARS-CoV-2 病毒 NSP12-NSP7-NSP8 和 NSP3 的结合部位,以及 COVID-19 治疗的替代潜在药物。
Protein J. 2020 Dec;39(6):619-630. doi: 10.1007/s10930-020-09942-9. Epub 2020 Nov 13.
4
Exploration of Specific Fluoroquinolone Interaction with SARS-CoV-2 Main Protease (Mpro) to Battle COVID-19: DFT, Molecular Docking, ADME and Cardiotoxicity Studies.探索氟喹诺酮类药物与 SARS-CoV-2 主蛋白酶(Mpro)的特异性相互作用以对抗 COVID-19:DFT、分子对接、ADME 和心脏毒性研究。
Molecules. 2024 Oct 5;29(19):4721. doi: 10.3390/molecules29194721.
5
Investigation of the molecular structure of CHBP, biological activities and SARS-CoV-2 protein binding interaction by molecular and biomolecular spectroscopy approaches.采用分子和生物分子光谱学方法研究 CHBP 的分子结构、生物活性和与 SARS-CoV-2 蛋白的结合相互作用。
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Dec 5;322:124853. doi: 10.1016/j.saa.2024.124853. Epub 2024 Jul 21.
6
Allergen fragrance molecules: a potential relief for COVID-19.过敏原香味分子:COVID-19 的潜在缓解剂。
BMC Complement Med Ther. 2021 Jan 21;21(1):41. doi: 10.1186/s12906-021-03214-4.
7
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.经 FDA 批准和正在研究的药物针对 SARS-CoV-2 刺突蛋白和主蛋白酶的再利用潜力,以及通过机器学习算法进行验证。
Chem Biol Drug Des. 2021 Apr;97(4):836-853. doi: 10.1111/cbdd.13812. Epub 2020 Dec 22.
8
Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation.SARS-CoV-2 中 RB 结构域突变变异的基因组多样性和分子动力学相互作用及其对药物失活的影响。
Infect Genet Evol. 2022 Jan;97:105128. doi: 10.1016/j.meegid.2021.105128. Epub 2021 Nov 6.
9
Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.利用 Spike 的适体功能化脂质纳米粒特异性递送 RNAi 靶向 SARS-CoV-2:临床病例研究中的强力抗新冠病毒药物。
Chem Biol Drug Des. 2022 Feb;99(2):233-246. doi: 10.1111/cbdd.13978. Epub 2021 Nov 24.
10
In silico molecular docking studies of certain commercially available flavonoids as effective antiviral agents against spike glycoprotein of SARS-CoV-2.基于计算机的分子对接研究某些市售类黄酮作为抗 SARS-CoV-2 刺突糖蛋白的有效抗病毒药物。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6741-6744. doi: 10.26355/eurrev_202111_27119.

引用本文的文献

1
Importance of Computer-aided Drug Design in Modern Pharmaceutical Research.计算机辅助药物设计在现代药物研究中的重要性。
Curr Drug Discov Technol. 2025;22(3):e15701638361318. doi: 10.2174/0115701638361318241230073123.
2
Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors.作为MDM2-p53抑制剂的螺环氧化吲哚衍生物的合成、晶体结构、 Hirshfeld表面、计算及生物学研究
Mol Divers. 2025 Jun;29(3):2157-2177. doi: 10.1007/s11030-024-10974-x. Epub 2024 Aug 29.
3
Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M) of SARS-CoV-2: A hybrid approach consisting of molecular docking, MD simulations and MMPBSA analysis.

本文引用的文献

1
Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.新型香豆素类似物的合成:SARS-CoV-2蛋白与天然和合成香豆素类似物的分子对接相互作用研究及其药代动力学研究。
Saudi J Biol Sci. 2021 Jan;28(1):1100-1108. doi: 10.1016/j.sjbs.2020.11.038. Epub 2020 Nov 12.
2
Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds.来源于 N-取代色胺酮化合物的 SARS-CoV-2 3C 样蛋白酶的有效抑制剂。
Eur J Med Chem. 2020 Nov 15;206:112702. doi: 10.1016/j.ejmech.2020.112702. Epub 2020 Aug 1.
3
探索新型哌啶衍生物对新型冠状病毒 2 型主要蛋白酶(M)的抑制潜力:一种由分子对接、分子动力学模拟和 MMPBSA 分析组成的混合方法。
J Mol Liq. 2023 Jul 15;382:121904. doi: 10.1016/j.molliq.2023.121904. Epub 2023 Apr 26.
4
Study of Genotoxicity, Activities on Caspase 8 and on the Stabilization of the Topoisomerase Complex of Isoeleutherin and Analogues.异冬氨酸及其类似物的遗传毒性、对 Caspase 8 的活性及拓扑异构酶复合物稳定性的研究。
Molecules. 2023 Feb 8;28(4):1630. doi: 10.3390/molecules28041630.
5
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications.哌啶衍生物:合成与药理学应用的最新进展。
Int J Mol Sci. 2023 Feb 2;24(3):2937. doi: 10.3390/ijms24032937.
6
characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line.在 MDA-MB-231 乳腺癌细胞系中鉴定和合理模拟新型端粒酶组装抑制剂。
Oncol Rep. 2022 Nov;48(5). doi: 10.3892/or.2022.8403. Epub 2022 Sep 14.
7
Synthesis of new Spiropyrazole derivatives under microwaves irradiation and docking study for inhibition the microbes and COVID-19.微波辐射下新型螺吡唑衍生物的合成及其对微生物和新冠病毒抑制作用的对接研究
J Mol Struct. 2022 Dec 5;1269:133581. doi: 10.1016/j.molstruc.2022.133581. Epub 2022 Jun 25.
8
Pyrazolone-type compounds: synthesis and assessment of antiviral potential against key viral proteins of SARS-CoV-2.吡唑啉酮类化合物:针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键病毒蛋白的合成及抗病毒潜力评估
RSC Adv. 2022 May 27;12(25):16054-16070. doi: 10.1039/d2ra02542f. eCollection 2022 May 23.
9
New bis hydrazone: Synthesis, X-ray crystal structure, DFT computations, conformational study and study of the inhibition activity of SARS-CoV-2.新型双腙:合成、X射线晶体结构、密度泛函理论计算、构象研究及对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抑制活性的研究
J Mol Struct. 2022 Aug 5;1261:132865. doi: 10.1016/j.molstruc.2022.132865. Epub 2022 Mar 20.
10
Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via studies.新型含1,2,3-三唑单元的邻苯二甲酰亚胺衍生物的合成、光谱表征及通过研究作为潜在的SARS-CoV-2抑制剂的考察。
J Mol Struct. 2022 Aug 5;1261:132915. doi: 10.1016/j.molstruc.2022.132915. Epub 2022 Mar 23.
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
通过计算药物再利用研究鉴定针对 SARS-CoV-2 的 NSP16 的有前途的药物候选物。
J Biomol Struct Dyn. 2021 Oct;39(17):6713-6727. doi: 10.1080/07391102.2020.1802349. Epub 2020 Aug 3.
4
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.通过对 6 亿种化合物的虚拟筛选鉴定出新型冠状病毒蛋白酶的潜在抑制剂。
Int J Mol Sci. 2020 May 21;21(10):3626. doi: 10.3390/ijms21103626.
5
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.一种 SARS-CoV-2 病毒 RNA 复制机器的结构视图:RNA 合成、校对和最终加帽。
Cells. 2020 May 20;9(5):1267. doi: 10.3390/cells9051267.
6
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.通过计算药物再利用研究快速鉴定可能用于治疗冠状病毒病 19(COVID-19)的药物。
J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4.
7
Structure of the RNA-dependent RNA polymerase from COVID-19 virus.COVID-19 病毒的依赖 RNA 的 RNA 聚合酶的结构。
Science. 2020 May 15;368(6492):779-782. doi: 10.1126/science.abb7498. Epub 2020 Apr 10.
8
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
9
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.抗 HCV,核苷酸抑制剂,重新用于 COVID-19。
Life Sci. 2020 May 1;248:117477. doi: 10.1016/j.lfs.2020.117477. Epub 2020 Feb 28.
10
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.